Goldman Sachs
Singular Genomics Ups IPO Target to $187M
The San Diego-based DNA sequencing startup plans to offer 8.5 million shares at an IPO price between $20 and $22 per share, for a $1.5 billion valuation.
Sequencing Startup Singular Genomics Files for $100M IPO
The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis.
Twist Bioscience Proposes $250M Public Offering
Included in the offering — Twist Bioscience's third this year — are 75,000 shares of common stock offered by certain selling shareholders.
Sema4 Raises $121M in Series C Financing Round
BlackRock, the world's largest investment manager, led the round, joined by new investors Deerfield Management and Moore Strategic Ventures as well as existing investors.
Adaptive Biotechnologies to Raise $240M in Public Stock Offering
The offering consists of 8 million shares at an offering price of $40 per share, of which 2 million are being sold by a shareholder.